The Riverside Company, a global private investor focused on the smaller end of the middle market, has signed a definitive agreement to acquire a controlling stake in BioDue S.p.A (BioDue), an Italian company specialized in the development, manufacturing and commercialization of food supplements, medical devices and cosmetics.
Founded in 1986 by the Benedetti family, BioDue is one of the leading dietary supplements and medical devices companies in Italy. The company provides customers with a full-service offering, ranging from raw material sourcing development and formulation, production, packaging and regulatory affairs, to commercialization.
Riverside intends to pursue a pan-European buy-and-build strategy with BioDue, in what is a fragmented market, and already has several add-on targets under evaluation. At the same time, the firm will seek to enhance BioDue’s one-stop-shop offering and expand its breadth of product ranges across galenic forms and therapeutic areas.
Kommentare